Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 2/20 | 0.40 |
| ▸ | HTR7 | P34969 | 6/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | HTR5A | P47898 | 2/20 | 0.38 |
| ▸ | HTR6 | P50406 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HTR1D | P28221 | 1/20 | 0.38 |
| ▸ | HTR1B | P28222 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32680963 | 0.85 | PTGDR2 (0.44) | PTGDR2FYNHTR7XDHHTR1A | |
| SCHEMBL32680940 | 0.83 | PTGDR2 (0.42) | PTGDR2FYNHTR7XDHHTR1A | |
| SCHEMBL32680802 | 0.82 | PTAFR (0.35) | KDM4EALDH1A1HPGDNPC1RAB9A | |
| SCHEMBL4755042 | 0.81 | ALDH1A1 (0.41) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL11673547 | 0.81 | NAAA (0.50) | PTGDR2HTR7XDHNPC1RAB9A | |
| SCHEMBL32680945 | 0.74 | MAPT (0.37) | KDM4EALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL32680956 | 0.73 | GCGR (0.39) | HTR7LMNATP53MAPT | |
| SCHEMBL32680888 | 0.73 | PDK2 (0.41) | ALDH1A1NPC1RAB9ALMNAMAPT | |
| SCHEMBL18326857 | 0.71 | CYP1A1 (0.38) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL32680961 | 0.71 | GRM2 (0.43) | PTGDR2FYNHTR7KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | claimed |
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | BLM, MEF2D, SNCA | PTGDR2 2885/4885FYN 1442/4885HTR7 4316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.